Literature DB >> 9380714

Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents.

S Sharma1, F Murai, A Miyanohara, T Friedmann.   

Abstract

Retrovirus packaging cell lines expressing the Moloney murine leukemia virus gag and pol genes but lacking virus envelope genes produce virus-like particles constitutively, whether or not they express a transcript from an integrated retroviral provirus. In the absence of a proviral transcript, the assembled particles contain processed gag and reverse transcriptase, and particles made by cells expressing an integrated lacZ provirus also contain viral RNA. The virus-like particles from both cell types are enveloped and are secreted/budded into the extracellular space but are noninfectious. Their physicochemical properties are similar to those of mature retroviral particles. The noninfectious gag pol RNA particles can readily be made infectious by the addition of lipofection reagents to produce preparations with titers of up to 10(5) colony-forming units per ml.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9380714      PMCID: PMC23491          DOI: 10.1073/pnas.94.20.10803

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.

Authors:  Y Xiang; T W Ridky; N K Krishna; J Leis
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  WW domains and retrovirus budding.

Authors:  L Garnier; J W Wills; M F Verderame; M Sudol
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

3.  Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector.

Authors:  S Sharma; M Cantwell; T J Kipps; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates.

Authors:  P Spearman; L Ratner
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery.

Authors:  N V Somia; M Zoppé; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

Review 6.  Generation of high-titer pseudotyped retroviral vectors with very broad host range.

Authors:  J K Yee; T Friedmann; J C Burns
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

7.  Tissue-specific targeting of retroviral vectors through ligand-receptor interactions.

Authors:  N Kasahara; A M Dozy; Y W Kan
Journal:  Science       Date:  1994-11-25       Impact factor: 47.728

8.  Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents.

Authors:  J McDermott; L Farrell; R Ross; E Barklis
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

9.  A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes.

Authors:  J K Yee; A Miyanohara; P LaPorte; K Bouic; J C Burns; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

10.  Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.

Authors:  L J Parent; R P Bennett; R C Craven; T D Nelle; N K Krishna; J B Bowzard; C B Wilson; B A Puffer; R C Montelaro; J W Wills
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  13 in total

1.  Separable mechanisms of attachment and cell uptake during retrovirus infection.

Authors:  S Sharma; A Miyanohara; T Friedmann
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes.

Authors:  Ning Chai; Ho Eun Chang; Emmanuelle Nicolas; Severin Gudima; Jinhong Chang; John Taylor
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

3.  Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein.

Authors:  A Abe; A Miyanohara; T Friedmann
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

4.  Cell Membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells.

Authors:  Md Nasimuzzaman; Derek A Persons
Journal:  Mol Ther       Date:  2012-03-20       Impact factor: 11.454

5.  Design of hybrid lipid/retroviral-like particle gene delivery vectors.

Authors:  Rahul K Keswani; Ian M Pozdol; Daniel W Pack
Journal:  Mol Pharm       Date:  2013-03-26       Impact factor: 4.939

6.  Efficient in vitro gene delivery by hybrid biopolymer/virus nanobiovectors.

Authors:  Rahul Keswani; Kai Su; Daniel W Pack
Journal:  J Control Release       Date:  2014-07-08       Impact factor: 9.776

7.  Venezuelan equine encephalitis virus infection of mosquito cells requires acidification as well as mosquito homologs of the endocytic proteins Rab5 and Rab7.

Authors:  Tonya M Colpitts; Andrew C Moore; Andrey A Kolokoltsov; Robert A Davey
Journal:  Virology       Date:  2007-08-20       Impact factor: 3.616

8.  In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.

Authors:  A Abe; S T Chen; A Miyanohara; T Friedmann
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.

Authors:  Tsanan Giroglou; Jindrich Cinatl; Holger Rabenau; Christian Drosten; Harald Schwalbe; Hans Wilhelm Doerr; Dorothee von Laer
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Enhanced transgenesis by intracytoplasmic injection of envelope-free lentivirus.

Authors:  Shang-Hsun Yang; Yuksel Agca; Pei-Hsun Cheng; Jin-Jing Yang; Cansu Agca; Anthony Wing Sang Chan
Journal:  Genesis       Date:  2007-04       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.